Methaemoglobinaemia and renal failure following mesalazine for treatment of inflammatory bowel disease.
Service de Gastroentérologie et Hépatologie, CHU Dinant-Godinne/UCL Namur, Belgium. Electronic address: druez.anne@gmail.com.
Anne
A
Druez
Service de Gastroentérologie et Hépatologie, CHU Dinant-Godinne/UCL Namur, Belgium.
Jean-François
JF
Rahier
Service de Gastroentérologie et Nutrition, CHU Nice, Hôpital l'Archet 2, France.
Xavier
X
Hébuterne
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D019804:Mesalamine / Q000009:adverse effects* / Q000627:therapeutic use; D008708:Methemoglobinemia / Q000139:chemically induced*; D051437:Renal Insufficiency / Q000139:chemically induced*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D019804:Mesalamine